# Tirofiban

## Aggrastat inj 12.5mg/50mL

##### 

| TAH Drug Code      | IAGG                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Unstable angina/non-ST-elevation myocardial infarction: To decrease the rate of thrombotic cardiovascular events (combined end point of death, MI, or refractory ischemia/repeat cardiac procedure) in patients with non-ST-elevation acute coronary syndrome (unstable angina/non-ST-elevation myocardial infarction.                                                      |
| Dosing             | NSTE-ACS: (combined with heparin) loading infusion rate as 0.4 mcg/kg/min for 30 minutes, followed by 0.1 mcg/kg/min as maintenance infusion rate for at least 48 hours, up to 108 hours. PCI: (combined with heparin) initial bolus 25 mcg/kg for at least 3 minutes, followed by 0.15 mcg/kg/min as maintenance infusion rate for 12-24 hours, do not more than 48 hours. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                    |
| Contraindications  | Severe hypersensitivity reaction (ie, anaphylactic reaction) to tirofiban or any component of the formulation; history of thrombocytopenia following prior exposure to tirofiban; active internal bleeding or a history of bleeding diathesis, major surgical procedure, or severe physical trauma within the previous month.                                               |
| Adverse Effects    | >10%: Minor hemorrhage 1% to 10%:Coronary artery dissection, bradycardia, edema, vasodepressor syncope, dizziness, headache, diaphoresis, nausea, pelvic pain, major hemorrhage, leg pain, fever.                                                                                                                                                                           |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                                                  |
| Lactation          | Hold Breast Feeding                                                                                                                                                                                                                                                                                                                                                         |

